УЗЛОВОЙ КОЛЛОИДНЫЙ ЗОБ: РЕЗУЛЬТАТЫ ПРОСПЕКТИВНЫХ КОНТРОЛИРУЕМЫХ ИССЛЕДОВАНИЙ (Обзор литературы)

1. Мельниченко Г.А., Фадеев В.В. Узловой зоб: Первые результаты анкетирования российских эндокринологов // Клиническая тиреоидология. 2003. N 4. C. 18-21.

2. AACE Clinical Practice Guidelines for the Diagnosis and Management of Thyroid Nodules // Endocr. Pract. 1996. V. 2. P. 78-84.

3. AACE Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer // Endocr. Pract. 2006. V. 12. P. 63-102.

4. Alexander E.K., Hurwitz S., Heering J.P. et al. Natural history of benign solid and cystic thyroid nodules // Ann. Intern. Med. 2003. V. 138. P. 315-318.

5. Appetecchia M. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study // Horm. Res. 2005. V. 64. Р 293-298.

6. Aytac B., Karamercan A. Recurrent laryngeal nerve injury and preservation in thyroidectomy // Saudi Med. J. 2005. V. 26. P. 1746-1749.

7. Baldini M., Gallazzi M., Orsatti A. et al. Treatment of benign nodular goitre with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size // J. Intern. Med. 2002. V. 251. P. 407-414.

8. Bauer D.C., Ettinger B., Nevitt M.C. et al. Risk for fracture in women with low serum levels of thyroid-stimulating hormone // Ann. Intern. Med. 2001. V. 134. P. 561-568.

9. Bennedbaek F.N., Perrild H., Hegedüs L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey // Clin. Endocrinol. (Oxf). 1999. V. 50. P. 357-363.

10. Berghout A., Wiersinga W.M., Drexhage H.A. The long-term outcome of thyroidectomy for sporadic non-toxic goiter // Clin. Endocrinol. (Oxf.). 1989. V. 31.P. 193-199.

11. Berghout A., Wiersinga W.M., Smits N.J., Touber J.L. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter // Am. J. Med. 1990. V. 89. P. 602-608.

12. Biondi B., Fazio S., Carella C. et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine // J. Clin. Endocrinol. Metab. 1993. V. 77 P. 334-338.

13. Boelaert K., Horacek J., Holder R.L. et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration // J. Clin. Endocrinol. Metab. 2006. V. 91. P. 4295-4301.

14. Bonnema S.J., Bennedboek F.N., Landenson P.W., Hegedus L. Management of the nontoxic multinodular goiter: a North American syrvey // Clin. Endocrinol. Metab. 2002. V. 87. P. 112-117.

15. Bonnema S.J., Bennedboek F.N., Wiersinga W.M., Hegedus L. Management of the nontoxic multinodular goiter: a European questionnaire study // Clin. Endocrinol. (Oxf) 2000. V. 53. P. 5-12.

16. Celani M.F., Mariani M., Mariani G. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules // Acta Endocrinol. 1990. V. 123. P. 603-608.

17. Cheung P.S., Lee J.M., Boey J.H. Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study // World J. Surg. 1989. V. 13. P. 818-821.

18. Colak T., Akca T., Kanik A. et al. Total versus subtotal thyroidectomy for the management of benign multinodular goiter in an endemic region // ANZ J. Surg. 2004. V. 74. P. 974- 978.

19. Danaci M., Veek C.M., Notghi A. et al. 131I radioiodine therapy for hyperthyroidism in patients with Graves, disease, uninodular goiter and multinodular goiter // NZ Med. J. 1988. V. 101. P. 784-786.

20. Diacinti D., Salabи G.B., Olivieri A. et al. Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG) // Minerva Med. 1992. V. 83. P. 745-751.

21. Dietlein M., Dederichs B., Kobe C. et al. Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery // Nuklearmedizin. 2006. V. 45. P. 21-34.

22. Einenkel D., Bauch K.H., Benker G. Treatment of juvenile goiter with levothyroxine, iodide or a combination of both: the value of ultrasound grey-scale analysis // Acta Endocrinol. 1992. V. 127. P. 301-306.

23. Elte J.W., Bussemaker J.K., Haak A. The natural history of euthyroid multinodular goiter // Postgrad. Med. J. 1990. V. 66. P. 186-190.

24. Faber J., Galloe A.M. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a metaanalysis // Eur. J. Endocrinol. 1994. V. 130. P. 350—356.

25. Gharib H. Fine needle aspiration biopsy of thyroid nodules // Mayo Clin. Proc. 1994. V. 69. P. 44—52.

26. Gosnell J.E., Sackett W.R., Sidhu S. et al. Minimal access thyroid surgery: technique and report of the first 25 cases // ANZ J. Surg. 2004. V. 74. P. 330—334.

27. Gullu S., Gürses M.A., Baekal N. et al. Suppressive therapy with levothyroxine for euthyroid diffuse and nodular goiter // Endocr. J. 1999. V. 46. P. 221—226.

28. Hansen J.M., Kampmann J., Madsen S.N. et al. L-Thyroxine treatment of diffuse non-toxic foiter evaluated by ultrasonic determination of thyroid volume // Clin. Endocrinol. 1979. V. 10. P. 1—6.

29. Hintze G., Emrich D., Koebberling J. Treatment of endemic goiter due to iodine deficiency with iodine, levothyroxine or both: results of a multicentre trial // Eur. J. Clin. Invest. 1989. V. 19. Р. 527—534.

30. Kraimps J.L., Marechaud R., Gineste D. et al. Analysis and prevention of recurrent goiter // Surg. Gynecol. Obstet. 1993. V. 176. P. 319—322.

31. La Rosa G.L., Lupo L., Giuffrida D. et al. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid // Ann. Intern. Med. 1995. V. 122. P. 1—8.

32. Larijani B., Pajouhi M., Bastanhagh M.H. et al. Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial // Endocr. Pract. 1999. V. 5. P. 251—256.

33. Latapie J.L., Leprat F., N’Guyen D. et al. Hormonal suppressive therapy of thyroid nodules // Ann. Endocrinol. 1997 V. 58. P. 459—462.

34. Le Moli R., Wesche M.F., Tiel-Van Buul M.M., Wiersinga WM. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre // Clin. Endocrinol. (Oxf). 1999. V. 50. P. 783—789.

35. Lima N., Knobel M., Cavaliere H. et al. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters // Thyroid. 1997. V. 7. P. 691—697.

36. Lozano-Gymez M.J., Sànchez-Blanco J.M., Vàzquez-Moryn M. et al. Hemithyroidectomy in a unilateral goiter: a valid therapeutic option. Review of the contralateral hemithyroid ten years after treatment // Cir. Esp. 2006. V. 80. P. 23—26.

37. Mainini E., Martinelli I., Morandi G. et al. Levothyroxine suppressive therapy for solitary thyroid nodule // J. Endocrinol. Invest. 1995. V. 18. P. 796—799.

38. Mazzaferri E.L. Management of a solitary thyroid nodule // N. Engl. J. Med. 1993. V. 328. P. 553—559.

39. Meskhi I., Sikharulidze E., Lomidze N. et al. Effectiveness of percutaneous ethanol injection therapy in benign nodular and cystic thyroid diseases: 12-month follow-up experience // Georgian Med. News. 2006. V. 140. P. 7—10.

40. Mishra A., Agarwal A., Agarwal G., Mishra S.K. Total thyroidectomy for benign thyroid disorders in an endemic region // World J. Surg. 2001. V. 25. P. 307—310.

41. Morita T., Tamai H., Ohshima A. et al. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules // J. Clin. Endocrinol. Metab. 1989. V. 69. P. 227—230.

42. Nieuwlaat W.A., Huysmans D.A., van den Bosch H.C. et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter // J. Clin. Endocrinol. Metab. 2003. V. 88. P. 3121—3129.

43. Nygaard B., Hegedüs L., Gervil M. et al. Radioiodine treatment of multinodular non-toxic goitre // BMJ. 1993. V. 307. P. 828—832.

44. Pacella C.M., Bizzarri G., Spiezia S. et al. Thyroid tissue: US-guided percutaneous laser thermal ablation // Radiology. 2004. V. 232. P. 272—280.

45. Papini E., Guglielmi R., Bianchini A. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features // J. Clin. Endocrinol. Metab. 2002. V.87 P. 1941—1946.

46. Papini E., Guglielmi R., Bizzarri G. et al. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up // Thyroid. 2007. V. 17. P. 229—235.

47. Papini E., Petrucci L., Guglielmi R. et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules // J. Clin. Endocrinol. Metab. 1998. V. 83. P. 780—783.

48. Parle J.V., Maisonneuve P., Sheppard M.C. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result a 10-year cohort study // Lancet. 2001. V. 358. P. 861—865.

49. Plummer H.S. The clinical and pathologic relationship of hyperplastic and nonhyperplastic goiters // JAMA. 1913. V. 61. P. 650.

50. Quadbeck B., Pruellage J., Roggenbuck U. et al. Long-term follow-up of thyroid nodule growth // Exp. Clin. Endocrinol. Diabetes. 2002. V. 110. P. 348—354.

51. Reeve T.S., Delbridge L., Cohen A., Crummer P. Total thyroidectomy The preferred option for multinodular goiter // Ann. Surg. 1987. V. 206. P. 782—786.

52. Reverter J.L., Lucas A., Salinas I. et al. Suppressive therapy with levothyroxine for solitary thyroid nodules // Clin. Endocrinol. 1992. V. 36. P. 25—28.

53. Sawin C.T., Bigos S.T., Land S., Bacharach P. The aging thyroid: relationship between elevated thyrotropin levels and thyroid antibodies in elderly patients // Am. J. Med. 1985. V. 79 P. 591—595.

54. Scerrino G., Salamone G., Farulla M.A. et al. Non-toxic multinodular goitre: which surgery? // Ann. Ital. Chir. 2001. V. 72. P. 647—651.

55. Sdano M.T., Falciglia M., Welge J.A., Steward D.L. Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials // Otolaryngol. Head. Neck. Surg. 2005. V. 133. P. 391—396.

56. Seiler C.A., Glaser C., Wagner H.E. Thyroid gland surgery in endemic regon // World J. Surg. 1996. V. 20. P. 307—310.

57. Silva M.N., Rubiy I.G., Romгo R. et al. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goiters // Endocrinol. 2004. V. 60. P. 300—308.

58. Solymosi T., Gàl I. Treatment of recurrent nodular goiters with percutaneous ethanol injection: a clinical study of twelve patients // Thyroid. 2003. V. 13. P. 273—277.

59. Suliman N.N., Ryttov N.F., Qvist N. Experience in a specialist thyroid surgery unit a demographic study surgical complications and outcome // Eur. J. Surg. 1997. V. 163. P. 13-20.

60. Tan G.H., Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging // Ann. Int. Med. 1997. V. 126. P. 226-231.

61. Taneri F., Kurukahvecioglu O., Ege B. et al. Prospective analysis of 518 cases with thyroidectomy in Turkey // Endocr. Regul. 2005. V. 39. P. 85-90.

62. Tsai C.C., Pei D., Hung Y.J. et al. The effect of thyroxine-suppressive therapy in patients with solitary non-toxic thyroid nodules - a randomised, double-blind, placebo-controlled study // Int. J. Clin. Pract. 2006. V. 60. P. 23-26.

63. van Isselt J.W., van Dongen A.J. The current status of radioiodine therapy for benign thyroid disorders // Hell. J. Nucl. Med. 2004. V.7. P. 104-110.

64. Wadström C., Zedenius J., Guinea A. еt al. Multinodular goitre presenting as a clinical single nodule: how effective is hemithyroidectomy? // Aust. NZJ Surg. 1999. V. 69. P. 34-36.

65. Wang C., Crapo L.M. The epidemiology of thyroid disease and implications for screening // Endocrinol. Metab. Clin. North. Am. 1997. V. 26. P. 189-218.

66. Wemeau J.L., Caron P., Schvartz C. et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular non-palpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group // J. Clin. Endocrinol. Metab. 2002. V. 87. P. 4928-4934.

67. Wesche M.F., Tiel-Van Buul M.M., Lips P. et al. A randomized trial comparing levothyroxine with radioactive iodine in treatment of sporadic nontoxic goiter // J. Clin. Endocrinol. Metab. 2001. V. 86. P. 998-1005.

68. Zelmanovitz F., Genro S., Gross J.L. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses // J. Clin. Endocrinol. Metab. 1998. V. 83. P. 3881-3885.